Novosanis is an innovative developer and producer of medical devices improving the quality of diagnostic tests as well as the accuracy of drug delivery for infectious diseases and oncology.
Who is novosanis
Latest news
Breakthrough results on VAX-ID for kids at 12th Vaccine Conference
15/09/2018
Timothi Van Mulder will present Novosanis' breakthrough results on the development of a painless injection device for children at 12 th Vaccine Congress in Budapest, Hungary from September 16 to 19, 2018. His research on skin thickness in children from birth to adolescence as well as the...
Upcoming event
World Congress on Vaccines & Immunization
Osaka, Japan
Novosanis is attending the 30th World Congress on Vaccines & Immunization in Osaka, Japan on October 22 and 23, 2018. Our Clinical Affairs Manager, Timothi Van Mulder will be presenting our latest (pre)clinical data on the VAX-ID intradermal drug delivery device.
Events
Regulatory
Team
News